CVE detail

CVE-2007-6763 — CVE-2007-6763

Published 2019-07-31 · Modified 2026-06-16 · Vendor sas · Product sas_drug_development · Source nvd

HIGH

severity

CVSS-derived band

8.8

CVSS v3

0–10 scale

0.0132

EPSS probability

exploitation probability, 30d

68.0%

EPSS percentile

percentile vs all CVEs

NOT LISTED

CISA KEV

known exploited catalog

Description

SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.

Remediation

No vendor-published fix data in our corpus for this CVE. Check the references below or the vendor's PSIRT / security advisories page.

References

cvedb.io · NVD · CISA KEV · FIRST EPSS · vendor advisories (CVE Program List v5). Informational only, no warranty — verify every remediation against the vendor advisory before acting on it. This product uses data from the NVD API but is not endorsed or certified by the NVD, CISA, FIRST.org or any vendor named. CVE® is a registered trademark of The MITRE Corporation.